Endovenous Stenting

Medicare covers endovenous stent placement only for specified, symptomatic venous obstructions or complications when conservative therapy and/or angioplasty are suboptimal or have failed, and when a U.S. FDA–approved stent (or an IDE-authorized device under FDA conditions) is used. Coverage requires objective documentation (imaging, percent residual stenosis, failed conservative care), appropriate physician qualifications, and excludes preventive uses, stenting of popliteal/tibial veins, procedures for stenosis ≤50% (or residual stenosis <30%), and non-FDA-approved device use.

"Placement of an endovenous stent as an adjunct to a suboptimal or failed percutaneous transluminal angioplasty (PTA) when residual stenosis is >30% measured at the narrowest point of the lumen or w..."

Sign up to see full coverage criteria, indications, and limitations.